Inpex Corp (1605) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by the analyst to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:
Business description - A detailed description of the company’s operations and business divisions.
Corporate strategy - Analyst’s summarization of the company’s business strategy.
SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
Company history - Progression of key events associated with the company.
Major products and services - A list of major products, services and brands of the company.
Key competitors - A list of key competitors to the company.
Key employees - A list of the key executives of the company.
Executive biographies - A brief summary of the executives’ employment history.
Key operational heads - A list of personnel heading key departments/functions.
Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights
Inpex Corp (Inpex) is engaged in research, exploration, development, production, and sales of oil, natural gas, and other mineral resources. The company provides a range of services related to these activities, including investment and lending to companies involved in similar sectors. Inpex's operations are primarily focused on the energy sector, offering products and services that cater to the needs of industries requiring oil and natural gas. The company's offerings are utilized by various industries, including energy production and distribution. Inpex operates through a network of channel partners and distribution networks to reach its customers effectively. The company has a presence in multiple geographic locations, targeting markets across different regions. Inpex is headquartered in Minato-Ku, Tokyo, Japan.
Inpex Corp Key Recent Developments
Jun 17, 2026: INPEX Commences Hydrogen-Based Power Generation and Supply at Kashiwazaki Hydrogen Park in Niigata, Japan
Jun 16, 2026: INPEX Holds Eelgrass Transplanting Event as Part of Tokyo Bay UMI Project
Jun 04, 2026: INPEX CORPORATION, Osaka Gas Co., Ltd., and Mitsubishi Heavy Industries, Ltd. Start Operations in Nagaoka Methanation Demonstration Using CO2NNEX
May 21, 2026: Inpex signs agreements for offtake from Abadi LNG Project
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
Table of Contents
Section 1 - About the Company
Chugai Pharmaceutical Co Ltd - Key Facts
Chugai Pharmaceutical Co Ltd - Key Employees
Chugai Pharmaceutical Co Ltd - Key Employee Biographies
Chugai Pharmaceutical Co Ltd - Major Products and Services
Chugai Pharmaceutical Co Ltd - History
Chugai Pharmaceutical Co Ltd - Company Statement
Chugai Pharmaceutical Co Ltd - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 - Company Analysis
Company Overview
Chugai Pharmaceutical Co Ltd - Business Description
Other Break-up: Pharmaceutical Sales
Performance
Other Break-up: Royalties and Other Operating Income
Performance
Geographical Segment: Japan
Performance
Geographical Segment: Overseas
Performance
R&D Overview
Chugai Pharmaceutical Co Ltd - Corporate Strategy
Chugai Pharmaceutical Co Ltd - SWOT Analysis
SWOT Analysis - Overview
Chugai Pharmaceutical Co Ltd - Strengths
Chugai Pharmaceutical Co Ltd - Weaknesses
Chugai Pharmaceutical Co Ltd - Opportunities
Chugai Pharmaceutical Co Ltd - Threats
Chugai Pharmaceutical Co Ltd - Key Competitors
Section 3 - Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 - Company’s Lifesciences Financial Deals and Alliances
Chugai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2020 to YTD 2026
Chugai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2020 to YTD 2026
Chugai Pharmaceutical Co Ltd, Recent Deals Summary
Section 5 - Company’s Recent Developments
Jun 30, 2026: Launch of Joint Research Using Real-World Data and Generative AI (LLM) to Improve the Accuracy and Efficiency of Identifying Candidate Patients for Clinical Trials
Jun 30, 2026: Roche Announcement on Enspryng Application for Thyroid Eye Disease Accepted by US FDA
May 26, 2026: Chugai Pharmaceutical Wins Imperial Invention Award for Recycling Antibody Technology
May 25, 2026: Chugai Pharmaceutical Makes Organizational and Personnel Changes
Apr 24, 2026: Chugai Pharmaceutical Announces Organizational and Personnel Changes, Effective July 1, 2026.
Apr 22, 2026: FJ3, API Manufacturing Building for Small Molecule and Macrocyclic Peptide Drugs at the Fujieda Plant, Receives the 2026 Facility of the Year Awards from ISPE in the Honorable Mention Category
Apr 06, 2026: Research Results on Immune Thrombocytopenia from a Joint Study with Osaka University’s IFReC Published in Blood
Apr 02, 2026: Announcement by Eli Lilly on Oral GLP-1 Receptor Agonist Foundayo (orforglipron)
Mar 19, 2026: Chugai Files Medical Device Application for Port Delivery Platform With Ranibizumab in Japan
Section 6 - Appendix
Methodology
Ratio Definitions
About the Analyst
Contact the Publisher
Disclaimer
List of Tables
Chugai Pharmaceutical Co Ltd, Key Facts
Chugai Pharmaceutical Co Ltd, Key Employees
Chugai Pharmaceutical Co Ltd, Key Employee Biographies
Chugai Pharmaceutical Co Ltd, Major Products and Services
Chugai Pharmaceutical Co Ltd, History
Chugai Pharmaceutical Co Ltd, Other Locations
Chugai Pharmaceutical Co Ltd, Subsidiaries
Chugai Pharmaceutical Co Ltd, Key Competitors
Chugai Pharmaceutical Co Ltd, Ratios based on current share price
Chugai Pharmaceutical Co Ltd, Annual Ratios
Chugai Pharmaceutical Co Ltd, Interim Ratios
Chugai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2020 to YTD 2026
Chugai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2020 to YTD 2026
Chugai Pharmaceutical Co Ltd, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List of Figures
Chugai Pharmaceutical Co Ltd, Performance Chart (2021 - 2025)
Chugai Pharmaceutical Co Ltd, Ratio Charts
Chugai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2020 to YTD 2026
Chugai Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2020 to YTD 2026
This product is a company SWOT Analysis. Each license type allows a set number of users to access the report. Please select an option from the list below. This product is a company SWOT Analysis. This is a single user license, allowing one user access to the product. The product is a PDF. This product is a company SWOT Analysis. This is a site license, allowing all users within a given geographical location of your organization access to the product. The product is a PDF.
The sample excerpt is provided to help you make an informed purchasing decision. It is not intended to serve as free content or replace a full report. To ensure the sample aligns with your specific needs, our team will contact you to better understand your requirements.
An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net
This report can be tailored to focus on a specific country, region, continent, or provide global coverage. Please indicate your regions of interest and share any additional questions you may have. Our team strives to respond to all inquiries within the same business day.
An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net